Published in JACC Cardiovasc Imaging on December 01, 2011
Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr (2005) 46.32
Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr (1990) 25.24
Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med (2000) 6.27
Role of right ventricular wall motion abnormalities in risk stratification and prognosis of patients referred for stress echocardiography. J Am Coll Cardiol (2007) 2.19
Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation (1994) 1.86
Heart muscle disease related to HIV infection: prognostic implications. BMJ (1994) 1.37
Congestive cardiomyopathy in association with the acquired immunodeficiency syndrome. N Engl J Med (1986) 1.34
Cardiovascular manifestations of HIV infection. Circulation (2002) 1.26
Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol (1999) 1.13
Myocardial contractile reserve on dobutamine echocardiography predicts late spontaneous improvement in cardiac function in patients with recent onset idiopathic dilated cardiomyopathy. J Am Coll Cardiol (1999) 1.07
Reversibility of cardiac abnormalities in human immunodeficiency virus (HIV)-infected individuals: a serial echocardiographic study. J Am Coll Cardiol (1991) 1.06
Incidence of the involvement of the cardiovascular system in HIV infection. AIDS (2003) 1.00
Physiologic mechanisms governing hemodynamic responses to positive inotropic therapy in patients with dilated cardiomyopathy. Circulation (1988) 0.95
Left ventricular inotropic reserve and right ventricular function predict increase of left ventricular ejection fraction after beta-blocker therapy in nonischemic cardiomyopathy. J Am Coll Cardiol (2001) 0.91
Low prevalence of cardiac abnormalities in an HIV-seropositive population on antiretroviral combination therapy. J Acquir Immune Defic Syndr (2001) 0.88
Left ventricular assist device placement in a patient with end-stage heart failure and human immunodeficiency virus. Interact Cardiovasc Thorac Surg (2009) 0.79
Full recovery from severe dilated cardiomyopathy in an HIV-infected patient. AIDS Read (2001) 0.79
[Prevalence of cardiomyopathy in HIV infection: prospective study on 158 HIV patients]. Med Mal Infect (2008) 0.79
Effect of highly active antiretroviral therapy on ischemic cardiovascular disease in patients with HIV-1 infection. Clin Infect Dis (2002) 0.78
Obesity paradox in patients with hypertension and coronary artery disease. Am J Med (2007) 5.61
Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials. BMJ (2013) 3.98
Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: an updated meta-analysis of randomized trials. J Am Coll Cardiol (2013) 2.99
Atrial fibrillation and obesity--results of a meta-analysis. Am Heart J (2007) 2.86
Half a century of hydrochlorothiazide: facts, fads, fiction, and follies. Am J Med (2011) 2.33
Role of left atrial size in risk stratification and prognosis of patients undergoing stress echocardiography. J Am Coll Cardiol (2007) 2.26
Role of right ventricular wall motion abnormalities in risk stratification and prognosis of patients referred for stress echocardiography. J Am Coll Cardiol (2007) 2.19
Procedural variation in the performance of primary percutaneous coronary intervention for ST-elevation myocardial infarction: a SCAI-based survey study of US interventional cardiologists. Catheter Cardiovasc Interv (2013) 2.02
Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-analysis of randomized trials. J Am Coll Cardiol (2011) 1.68
Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema. Am J Med (2011) 1.66
Body weight changes with beta-blocker use: results from GEMINI. Am J Med (2007) 1.60
Unusual anomalous single papillary muscle causing symptomatic mid-left ventricular cavity obstruction: octopus papillary muscle. J Am Soc Echocardiogr (2006) 1.54
Vascular closure device failure in contemporary practice. JACC Cardiovasc Interv (2012) 1.50
The safety of deFinity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses. J Am Soc Echocardiogr (2008) 1.46
Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction. Ann Thorac Surg (2003) 1.45
Standing and exercise Doppler echocardiography in obstructive hypertrophic cardiomyopathy: the range of gradients with upright activity. J Am Soc Echocardiogr (2010) 1.45
Diuretic-based regimens for obese patients? Lancet (2012) 1.45
Flash pulmonary oedema and bilateral renal artery stenosis: the Pickering syndrome. Eur Heart J (2011) 1.45
Triple versus dual antiplatelet therapy in acute coronary syndromes: adding cilostazol to aspirin and clopidogrel? Cardiology (2013) 1.44
Effect of obstruction on longitudinal left ventricular shortening in hypertrophic cardiomyopathy. J Am Coll Cardiol (2007) 1.42
Authors' reply to Laragh and Sealey. BMJ (2013) 1.40
Trials on the effect of cardiac resynchronization on arterial blood pressure in patients with heart failure. Am J Cardiol (2010) 1.38
Aspiration thrombectomy in patients undergoing primary angioplasty: totality of data to 2013. Catheter Cardiovasc Interv (2014) 1.33
Risk/benefit assessment of beta-blockers and diuretics precludes their use for first-line therapy in hypertension. Circulation (2008) 1.23
Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials. Circ Cardiovasc Interv (2012) 1.20
Using a multidisciplinary training program to reduce peritonitis in peritoneal dialysis patients. Perit Dial Int (2012) 1.09
Optimal renin-angiotensin system blockade-wishful thinking? Nat Rev Cardiol (2013) 1.08
Lipid-lowering in African Americans in ALLHAT-optimism bias? J Clin Hypertens (Greenwich) (2013) 1.06
Radiation exposure during coronary angiography via transradial or transfemoral approaches when performed by experienced operators. Am Heart J (2013) 1.01
Peripheral edema associated with calcium channel blockers: incidence and withdrawal rate--a meta-analysis of randomized trials. J Hypertens (2011) 1.01
Renal denervation for resistant hypertension? N Engl J Med (2014) 0.97
Pulse wave imaging in normal, hypertensive and aneurysmal human aortas in vivo: a feasibility study. Phys Med Biol (2013) 0.95
Association between Arsenic Exposure from Drinking Water and Longitudinal Change in Blood Pressure among HEALS Cohort Participants. Environ Health Perspect (2015) 0.93
Arterial embolism caused by large mobile aortic thrombus in the absence of atherosclerosis, associated with iron deficiency anemia. Echocardiography (2011) 0.92
Early intravenous beta-blockers in patients with acute coronary syndrome--a meta-analysis of randomized trials. Int J Cardiol (2012) 0.92
Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives. Vasc Health Risk Manag (2009) 0.92
Antihypertensive efficacy of aliskiren: is hydrochlorothiazide an appropriate benchmark? Circulation (2009) 0.92
Severe symptoms in mid and apical hypertrophic cardiomyopathy. Echocardiography (2009) 0.91
ALTITUDE trial and dual RAS blockade: the alluring but soft science of the surrogate end point. Am J Med (2013) 0.90
Facial edema induced by isotretinoin use: a case and a review of the side effects of isotretinoin. J Drugs Dermatol (2006) 0.89
Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes. N Engl J Med (2015) 0.88
Cardiovascular drugs and cancer: of competing risk, smallpox, Bernoulli, and d'Alembert. Eur Heart J (2012) 0.88
Risk stratification using stress echocardiography: incremental prognostic value over historic, clinical, and stress electrocardiographic variables across a wide spectrum of bayesian pretest probabilities for coronary artery disease. J Am Soc Echocardiogr (2007) 0.88
Assessment of left atrial appendage function with transthoracic tissue Doppler echocardiography. Eur J Echocardiogr (2009) 0.87
In-vivo Pulse Wave Imaging for arterial stiffness measurement under normal and pathological conditions. Conf Proc IEEE Eng Med Biol Soc (2011) 0.87
Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors. Am J Cardiol (2012) 0.86
Risk stratification of women with peripartum cardiomyopathy at initial presentation: a dobutamine stress echocardiography study. J Am Soc Echocardiogr (2005) 0.86
Chemoradiation therapy versus chemotherapy alone for gastric cancer after R0 surgical resection: a meta-analysis of randomized trials. Oncology (2014) 0.85
Novel stress echocardiographic model incorporating the extent and severity of wall motion abnormality for risk stratification and prognosis. Am J Cardiol (2004) 0.85
Identification of a field isolate of Fasciola hepatica resistant to albendazole and susceptible to triclabendazole. Vet Parasitol (2012) 0.84
Cardiac outcomes with submaximal normal stress echocardiography: a meta-analysis. J Am Coll Cardiol (2012) 0.84
Practical applications in stress echocardiography: risk stratification and prognosis in patients with known or suspected ischemic heart disease. J Am Coll Cardiol (2003) 0.84
Molecular characterization of the ITS-2 fragment of Paramphistomum leydeni (Trematoda: Paramphistomidae). Vet Parasitol (2010) 0.84
A prospective study of variability in systolic blood pressure and mortality in a rural Bangladeshi population cohort. Prev Med (2013) 0.84
Comparison of diastolic septal perforator flow velocities in hypertrophic cardiomyopathy versus hypertensive left ventricular hypertrophy. Am J Cardiol (2005) 0.84
Symptomatic exercise-induced left ventricular outflow tract obstruction without left ventricular hypertrophy. J Am Soc Echocardiogr (2013) 0.83
Usefulness of complex atherosclerotic plaque in the ascending aorta and arch for predicting cardiovascular events. Am J Cardiol (2002) 0.83
Transient ischemic left ventricular cavity dilation is a significant predictor of severe and extensive coronary artery disease and adverse outcome in patients undergoing stress echocardiography. J Am Soc Echocardiogr (2007) 0.83
Meta-analysis of cilostazol versus aspirin for the secondary prevention of stroke. Am J Cardiol (2013) 0.82
Long-term efficacy and safety of Zotarolimus-eluting stent in patients with diabetes mellitus: pooled 5-year results from the ENDEAVOR III and IV trials. Catheter Cardiovasc Interv (2013) 0.82
Right ventricular dysfunction is a strong predictor of developing atrial fibrillation in acutely decompensated heart failure patients, ACAP-HF data analysis. J Card Fail (2010) 0.82
Predictors of ischemia in patients referred for evaluation of exertional dyspnea: a stress echocardiography study. J Am Soc Echocardiogr (2012) 0.81
Prognostic implications of stress echocardiography and impact on patient outcomes: an effective gatekeeper for coronary angiography and revascularization. J Am Soc Echocardiogr (2010) 0.81
Dual RAS blockade-unresolved controversy? Nat Rev Nephrol (2013) 0.81
From door-to-balloon time to contact-to-device time: predictors of achieving target times in patients with ST-elevation myocardial infarction. Clin Cardiol (2014) 0.81
The effect of statin therapy on ventricular tachyarrhythmias: a meta-analysis. Am J Ther (2012) 0.80
Assessment of myocardial viability with dobutamine stress echocardiography in patients with ischemic left ventricular dysfunction. Echocardiography (2005) 0.80
The presence, characterization and prognosis of coronary plaques among patients with zero coronary calcium scores. Int J Cardiovasc Imaging (2010) 0.80
Reflections of inflections in hypertrophic cardiomyopathy. J Am Coll Cardiol (2009) 0.80
Angiotensin receptor blockers: baseline therapy in hypertension? Eur Heart J (2009) 0.80
When guidelines need guidance... Am J Med (2008) 0.79
Treatment-resistant hypertension: another Cinderella story. Eur Heart J (2013) 0.79
"One" cup of coffee and nuclear SPECT to go. J Am Coll Cardiol (2007) 0.79
Amiodarone-induced acute respiratory distress syndrome masquerading as acute heart failure. J Emerg Med (2011) 0.79
Complete revascularization in contemporary practice. Circ Cardiovasc Interv (2013) 0.79
A novel pathway for the management of hypertension for hospitalized patients. Crit Pathw Cardiol (2007) 0.79
Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: an updated review of literature. Curr Cardiol Rep (2014) 0.79
Resting heart rate and cardiovascular disease: the beta-blocker-hypertension paradox. J Am Coll Cardiol (2008) 0.78
Association of major dietary patterns and blood pressure longitudinal change in Bangladesh. J Hypertens (2015) 0.78
A routine invasive strategy for out-of-hospital cardiac arrest survivors: are we there yet? Circ Cardiovasc Interv (2010) 0.78
Telmisartan, ramipril, or both in patients at high risk of vascular events. N Engl J Med (2008) 0.78
Stress testing in patients with hypertrophic cardiomyopathy. Prog Cardiovasc Dis (2012) 0.78
Feasibility and prognostic value of stress echocardiography in obese, morbidly obese, and super obese patients referred for bariatric surgery. Echocardiography (2013) 0.78
Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease. N Engl J Med (2015) 0.78
Validation of long-term benefits of bivalirudin versus unfractionated heparin in routine clinical practice after percutaneous coronary intervention. Am J Cardiol (2010) 0.78
Comparison of heart rate reserve versus 85% of age-predicted maximum heart rate as a measure of chronotropic response in patients undergoing dobutamine stress echocardiography. Am J Cardiol (2006) 0.78
Concordance with DASH diet and blood pressure change: results from the Framingham Offspring Study (1991-2008). J Hypertens (2015) 0.78
How and when to decide on revascularization in stable ischemic heart disease. Curr Treat Options Cardiovasc Med (2013) 0.78